Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine.

Literature DB >> 29926370

Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine.

Leda Marina Pomes¹, Giovanna Gentile^2,3, Maurizio Simmaco^2,3, Marina Borro^2,3, Paolo Martelletti^4,5,6.

Abstract

Entities: Disease Species

Mesh：

Year: 2018 PMID： 29926370 DOI： 10.1007/s40263-018-0532-6

Source DB: PubMed Journal: CNS Drugs ISSN： 1172-7047 Impact factor: 5.749

× No keyword cloud information.

25 in total

1. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract.

Authors: Cédric Gaudineau; Rachel Beckerman; Sarah Welbourn; Karine Auclair
Journal: Biochem Biophys Res Commun Date: 2004-06-11 Impact factor: 3.575

Review 2. Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach.

Authors: Abouch Valenty Krymchantowski; Marcelo Eduardo Bigal
Journal: Expert Rev Neurother Date: 2006-03 Impact factor: 4.618

Review 3. Personalised Healthcare: The DiMA Clinical Model.

Authors: Marina Borro; Giovanna Gentile; Luigi Cipolloni; Zeno Foldes-Papp; Paola Frati; Alessandro Santurro; Luana Lionetto; Maurizio Simmaco
Journal: Curr Pharm Biotechnol Date: 2017 Impact factor: 2.837

4. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.

Authors: Steven H Yale; Ingrid Glurich
Journal: J Altern Complement Med Date: 2005-06 Impact factor: 2.579

5. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.

Authors: Bent H Hellum; Zhuohan Hu; Odd Georg Nilsen
Journal: Basic Clin Pharmacol Toxicol Date: 2007-01 Impact factor: 4.080

6. Pharmacogenetic insights into migraine treatment in children.

Authors: Giovanna Gentile; Lorenza Chiossi; Luana Lionetto; Paolo Martelletti; Marina Borro
Journal: Pharmacogenomics Date: 2014-08 Impact factor: 2.533

7. Migraine is first cause of disability in under 50s: will health politicians now take notice?

Authors: Timothy J Steiner; Lars J Stovner; Theo Vos; R Jensen; Z Katsarava
Journal: J Headache Pain Date: 2018-02-21 Impact factor: 7.277

Review 8. Pharmacokinetic drug-drug interaction and their implication in clinical management.

Authors: Caterina Palleria; Antonello Di Paolo; Chiara Giofrè; Chiara Caglioti; Giacomo Leuzzi; Antonio Siniscalchi; Giovambattista De Sarro; Luca Gallelli
Journal: J Res Med Sci Date: 2013-07 Impact factor: 1.852

9. Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center.

Authors: Marina de Tommaso; Vittorio Sciruicchio; Marianna Delussi; Eleonora Vecchio; Marvita Goffredo; Michele Simeone; Maria Grazia Foschino Barbaro
Journal: J Headache Pain Date: 2017-05-30 Impact factor: 7.277